BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11241410)

  • 1. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma.
    de Jong D; Vyth-Dreese F; Dellemijn T; Verra N; Ruskoné-Fourmestraux A; Lavergne-Slove A; Hart G; Boot H
    J Pathol; 2001 Mar; 193(3):318-24. PubMed ID: 11241410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Frutos B; Calleja JL; Sánchez-Godoy P; Bellas C
    Med Clin (Barc); 1998 Jan; 110(2):41-4. PubMed ID: 9534129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.
    Yamamoto H; Nakamura T; Matsuo K; Tajika M; Kawai H; Ohmiya N; Niwa Y; Goto H; Nakamura S
    Cancer Sci; 2008 Sep; 99(9):1769-73. PubMed ID: 18616679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
    Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
    Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
    Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected.
    Chang DK; Chin YJ; Kim JS; Jung HC; Kim CW; Song IS; Kim CY
    Hepatogastroenterology; 1999; 46(28):2694-700. PubMed ID: 10522067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
    Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
    Delchier JC
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MALT-type low-grade B-cell lymphomas of the stomach and Helicobacter pylori].
    Binek J; Morant R; Weber A; Schmid U; Hammer B
    Schweiz Med Wochenschr; 1996 May; 126(19):841-4. PubMed ID: 8693310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.